Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2022 Dec 10;19(24):16631.
doi: 10.3390/ijerph192416631.

COVID-19 Not Hypertension or Diabetes Increases the Risk of Preeclampsia among a High-Risk Population

Rachael Morris  1 , Ahmed S Z Moustafa  1 , Wondwosen Kassahun-Yimer  2 , Sarah Novotny  1 , Brittney Billsby  1 , Amira Abbas  3 , Kedra Wallace  1   4   5
Affiliations
Observational Study

COVID-19 Not Hypertension or Diabetes Increases the Risk of Preeclampsia among a High-Risk Population

Rachael Morris et al. Int J Environ Res Public Health. .

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) infection has been associated with greater morbidity and increased mortality in certain populations, such as those with chronic medical conditions, the elderly, and pregnant women. Our goal was to determine if COVID-19 infection during pregnancy increased the risk of preeclampsia in a population of women with increased risk factors for preeclampsia. We present a prospective observational matched case-control study of 100 deliveries with confirmed SARS-CoV2. Specifically, we investigated the maternal and neonatal outcomes in a high-risk population of pregnant women. Among women with COVID-19, the severity of symptoms was associated with the incidence of preeclampsia, but not with pre-existing diabetes or hypertension. Women with more severe symptoms were more likely to delivery pre-term with smaller babies. After adjusting for diabetes, hypertensive women with COVID-19 had an increased risk of preeclampsia aOR4.3 [1.5,12.4] compared to non-hypertensive women with COVID-19. After adjusting for hypertension, women with diabetes and COVID-19 had an increased risk of preeclampsia aOR3.9 [1.2,12.5]. This relationship was not seen among women without COVID-19. For women who had pre-existing diabetes or hypertension, the risk of developing preeclampsia was only increased if they were also diagnosed with COVID-19, suggesting that in our population of women the risk of preeclampsia is not associated with pre-existing diabetes or hypertension.

Keywords: SARS-CoV2; diabetes; hypertension; obesity; preeclampsia.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
(A). Body mass index was compared between women with and without preeclampsia (PreE) within racial and ethnic groups. (B). Infant birthweight was compared for the length of time between gestational age at COVID-19 diagnosis and gestational age at delivery. The number in white denotes the number of women in each category. (C). When differences in infant birthweight was adjusted for gestational age at delivery and then compared to the time interval between gestational age at COVID-19 diagnosis and gestational age at delivery, infants who were born less than 10 following a positive COVID-19 diagnosis had statistically lower weights relative to infants born 11–90 days following a positive maternal COVID-19 diagnosis. * denotes p < 0.05 between the indicated groups.
See this image and copyright information in PMC

References

    1. Di Martino D., Chiaffarino F., Patane L., Prefumo F., Vergani P., Ornaghi S., Savasi V., Spinillo A., Cromi A., D’Ambrosi F., et al. Assessing risk factors for severe forms of COVID-19 in a pregnant population: A clinical series from Lombardy, Italy. Int. J. Gynaecol. Obstet. 2021;152:275–277. doi: 10.1002/ijgo.13435. - DOI - PMC - PubMed
    1. Brandt J., Hill J., Reddy A., Schuster M., Patrick H., Rosen T., Sauer M., Boyle C., Anathy C. Epidemiology of coronavirus disease 2019 in pregnancy: Risk factors and associations with adverse maternal and neonatal outcomes. Am. J. Obstet. Gynecol. 2021;224:389.e1–389.e9. doi: 10.1016/j.ajog.2020.09.043. - DOI - PMC - PubMed
    1. Ellington S., Strid P., Tong V., Woodworth K., Galang R., Zambrano L., Nahabedian J., Anderson K., Gilboa S. Characteristics of Women of Reproductive Age with Laboratory-confirmed SARS-CoV-2 Infection by Pregnancy Status - United States, January 22–June 7, 2020. MMWR Morb. Mortal. Weekly Rep. 2020;69:769–775. doi: 10.15585/mmwr.mm6925a1. - DOI - PMC - PubMed
    1. Litman E., Yin Y., Nelson S., Capbarat E., Kerchner D., Ahmadzia H. Adverse Perinatal outcomes in a Large US Birth Cohort during the COVID-19 Pandemic: Adverse Perinatal Outcomes during COVID-19. Am. J. Obstet. Gynecol. 2022;4:10057. - PMC - PubMed
    1. Wang X., Chen X., Zhang K. Maternal infection with COVID-19 and increased risk of adverse pregnancy outcomes: A meta-analysis. J. Matern. Fetal Neonatal Med. 2022;35:9368–9375. doi: 10.1080/14767058.2022.2033722. - DOI - PubMed

Publication types